Anthony R. Chase, Director at AVI BIOPHARMA INC (AVII), bought 46,400 shares at $1.42 ($66K) on 2010-06-09, disclosed to the SEC on 2010-06-10.
Open-market purchase of $66k AVII by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 1,000 | $1K | 2.1% |
| 2 | $1.40 | 5,600 | $8K | 11.9% |
| 3 | $1.42 | 700 | $994 | 1.5% |
| 4 | $1.42 | 100 | $142 | 0.2% |
| 5 | $1.42 | 31,800 | $45K | 68.7% |
| 6 | $1.42 | 6,900 |
| $10K |
| 14.9% |
| 7 | $1.42 | 300 | $426 | 0.6% |
| Total | $1.42 avg | 46,400 | $66K | 100% |
| Filing → |
| LYB | BUY | 2023-07-10 | $3K | — | Filing → |
| APC | BUY | 2017-05-18 | $200K | — | Filing → |
| APC | BUY | 2014-09-02 | $189K | — | Filing → |